X-Message-Number: 21432
Date: Thu, 20 Mar 2003 02:52:21 -0500 (EST)
From: Charles Platt <>
Subject: Some SARS numbers

Initially the number of cases of a totally new infectious disease tends to
grow at an exponential rate, as each new patient infects a number of new
patients, who infect more patients, and so on, while the medical community
scrambles to catch up. Eventually the outbreak is contained (e.g. by a
strict quarantine policy), or a cure is found, or the virus uses up all
the potential victims. At this point the exponential curve turns into the
S curve that is familiar in many demographic phenomena. The big question
is how long we have to wait before the growth in SARS cases (which
currently appears to be exponential) levels off. I will be tracking the
number of announced cases during the next week or two in an effort to
determine whether SARS is still in the exponential growth phase.

Based on very fragmentary evidence, some from CDC, some from WHO, and some
from an ICU doctor in the Price of Wales hospital in Hong Kong, I will
assume tentatively that the average incubation period for SARS is about 5
days, and the average patient infects three new patients. In the US,
assuming we have 10 patients currently, the initial exponential growth
looks like this, assuming that a new patient does not become contagious
until the end of the 5-day incubation period (which may not in fact be
true):

5 days       30 patients
10 days      90 patients
15 days     270 patients
20 days     800 approx patients
25 days    2400 approx patients
30 days    7200 approx patients
35 days   21600 approx patients
40 days   65000 approx patients
45 days  200000 approx patients

Thus some time by mid-May we would expect to see about 1 person in 1000
infected in the USA. Now of course we may hope to see successful efforts
at containment before then. The trouble is, this virus(?) appears to be
highly contagious, contrary to news reports. So far as we know, at least
two people in Hong Kong caught it merely by sharing a hotel elevator
briefly with an infected person. Also the relatively long incubation
period means that by the time someone has been diagnosed, probably (s)he
has had time to infect more victims, who will not be identified until
another five days have passed.

Antiviral drugs may be effective, but their supply is limited, and I find
it hard to see how supplies can be ramped up at an exponential rate
proportionate with the rate of contagion. Also the most appropriate
antiviral drug in the United States can be prescribed only for Hepatitis
C, as a result of FDA restrictions. Simple precautions by individuals may
be more effective, such as wearing masks and gloves. Expect masks to be
as prevalent on the NY subway as they are on the Tokyo subway, within a
month.

As for mortality, the current figures are artifically low because many
"survivors" are being ventilated (oxygen forcibly administered via
endotrachial tube), and if the experiences in Hong Kong are any guide,
weaning people from the ventilators is problematic. Thus the patients who
are still alive may not stay alive. They are not, apparently, "getting
better" in the simple sense.

Moreover this virus appears to afflict young people as well as the
elderly. One patient in Hong Kong is a 23-year-old who was in good
physical shape before she was infected with SARS.

Consequently I am concerned about the immediate future. Personally I
live in a remote area where I can easily be self-sufficient in every
respect for 6 months or so. But by the end of that time, I will be forced
to rejoin society, where I believe the virus will be still active.

Also I think it is likely that at least one cryonics member will contract
this disease. Personally I question whether standby team members should
participate in that case, so long as the mode of transmission of the virus
is not fully understood and we do not know whether precautions provide
protection. I do not believe it is reasonable for any transport team
member to participate if there is a very high mortality risk. We have
handled HIV-positive patients and patients suffering hepatitis C, but SARS
looks much worse. Not only the standby team members, but the cryonics
organization itself will be endangered if a large number of key personnel
are wiped out. In any case a hospital may simply refuse to allow a SARS
patient to be taken for cryopreservation. Autopsy will be inevitable
during the early spread of this disease.

Currently there is a lot of conjecture. The virus may turn out to be less
infectious that I am suggesting. The medical community may do a fine job
of isolating cases. But in cryonics, where we are always weighing risks,
it doesn't hurt to make contingency plans. As a first step, I have asked
Larry Johnson, Alcor's new director of clinical services, to order some
really effective masks with HEPA filters. In conjunction with eye
protection, gowns, and gloves, this may enable us to deal with SARS cases.

Naturally I hope very much that my rather grim concerns are proven
groundless. Currently, it is too early to tell.

--Charles Platt

Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=21432